ABSTRACT
Abstract Existing medications i.e. the antipsychotic drugs are known to be effective in treating only the positive symptoms of schizophrenia, while being ineffective on negative and cognitive symptoms of the disease. In addition, these medications cause extrapyramidal symptoms, forcing many patients towards natural medicine in the hope of minimizing the unwanted adverse effects. Nardostachys jatamansi is a medicinal plant that has been traditionally prescribed for various types of brain disorders. The active constituents of the plant have beneficial effects on the negative and cognitive symptoms of schizophrenia. This study was designed to identify the active constituents of Nardostachys jatamansi with the highest binding affinities for the key macromolecular drug targets involved in the pathophysiology of schizophrenia and thereby elucidate the possible mechanism of action. These targets are dopamine receptors, Gamma-aminobutyric acid receptors, N-methyl-D-aspartate receptors and Phosphodiesterase 10A. The results of molecular docking showed that, β-sitosterol, chlorogenic acid, oleanic acid and ursolic acid, displayed high binding affinity toward all the macromolecular drug targets. Ligands with steroid backbone and pentacyclic triterpene structure have been found to possess high binding affinity toward the dopamine receptor and phosphodiesterase 10A. While ligands with carbonyl group form stronger binding interactions with the N-methyl-D-aspartate receptor.
Subject(s)
Plants, Medicinal/adverse effects , Research/classification , Pharmaceutical Preparations/analysis , Valerianaceae/classification , Nardostachys/adverse effects , Schizophrenia , Antipsychotic AgentsABSTRACT
Under the guidance of the traditional Chinese medicine(TCM) theory of "Zangfu-organs of spleen and stomach" and the modern theory of "microbiota-gut-brain axis", this study explored the effects of Nardostachys jatamansi on the gut microbiota of rats with Parkinson's disease(PD). The 40 SD rats were randomly divided into the control group, PD model group, levodopa group, and Nardostachys jatamansi ethanol extract group. The PD model was established by subcutaneous injection of rotenone in the neck and back area. After 14 days of intragastric administration, the PD rats' behaviors were analyzed through open field test, inclined plane test, and pole test. After the behavioral tests, the striatum, colon, and colon contents of rats in each group were collected. Western blot was employed to detect the protein expression of tyrosine hydroxylase(TH) and α-synuclein(α-syn) in striatum and that of α-syn in colon. Enzyme linked immunosorbent assay(ELISA) was used to detect the levels of tumor necrosis factor-α(TNF-α), interleukin-1β(IL-1β), and nuclear factor-kappa B(NF-κB) in striatum and colon. High-throughput sequencing of 16 S rRNA gene was conducted to detect the differences in microbial diversity, abundance, differential phyla, and dominant bacteria of rats between groups. The results indicated that Nar. ethanol extract could relieve dyskinesia, reverse the increased levels of α-syn, TNF-α, IL-1β, and NF-κB in striatum, and improve the protein expression of TH in striatum of PD rats. The α diversity analysis indicated a significant decrease in diversity and abundance of gut microbiota in the PD model. The results of linear discriminant analysis effect size(LEfSe) of dominant bacteria indicated that Nardostachys jatamansi ethanol extract increased the relative abundance of Clotridiaceae, Lachnospiraceae, and Anaerostipes, and reversed the increased relative abundance of Proteobacteria, Gammaproteobacteria, Enterobacteriaceae, and Escherichia-Shigella in PD model group to exhibit the neuroprotective effect. In summary, the results indicated that Nar. ethanol extract exert the therapeutic effect on PD rats. Specifically, the extract may regulate gut microbiota, decrease the levels of proinflammatory cytokines, and reduce the protein aggregation of α-syn in the colon and striatum to alleviate intestinal inflammation and neuroinflammation. This study provides a basis for combining the theory of "Zangfu-organs of spleen and stomach" with the theory of "microbiota-gut-brain axis" to treat PD.
Subject(s)
Animals , Rats , Gastrointestinal Microbiome , NF-kappa B/metabolism , Nardostachys/metabolism , Parkinson Disease/drug therapy , Rats, Sprague-DawleyABSTRACT
Nardostachyos Radix et Rhizoma is the dry root and rhizome of Nardostachys jatamansi （Valerianaceae） with a long medical history and a broad range of application， which is effective in regulating Qi， relieving pain， resolving depression， and enlivening spleen， as well as dispelling dampness and relieving swelling by external application. It can be used for the treatment of abdominal distension， loss of appetite， and vomiting. Besides， it can also relieve toothache and treat dermatophytosis and pyogenic infection by external use. Moreover， it serves as a common medicinal material in ancient Ayurveda and Unani medical systems in India and also as an ingredient in spices， foods， and cosmetics. Modern pharmacological studies have shown that Nardostachyos Radix et Rhizoma possesses multiple pharmacological activities， such as sedation， anti-epilepsy， anti-convulsion， anti-depression， anti-arrhythmia， anti-malaria， anti-inflammation， anti-bacteria， anti-oxidation， and blood sugar metabolism improvement due to its multiple compounds contained， including terpenes， flavonoids， coumarins， and lignans. The main active components are sesquiterpenoids represented by nardosinone. The pharmacological activities， chemical compositions， and clinical applications of Nardostachyos Radix et Rhizoma have been investigated， but the research on resources， distribution， quality control， cultivation status， and applications are rarely reported. As an important genuine medicinal material from the Qinghai-Tibet plateau， Nardostachyos Radix et Rhizoma is obtained mainly from wild N. jatamansi. Accordingly， the conservation and sustainable utilization of N. jatamansi have attracted much attention all around the world. Based on the resource survey， cultivation research， and relevant literature available， the present study reviewed resources， geographical distribution， chemical compositions， pharmacological activities， quality control， cultivation， and applications of N. jatamansi， aiming to provide references for the conservation and development of N. jatamansi.
ABSTRACT
Objective Based on the premise of wild resources protection of Nardostachys jatamansi, whether Nardostachys Herba (NH) could be equal to Nardostachys Radix et Rhizoma (NRR) specified in pharmacopeia for medical use or not, and to discuss the scientificity of using NH as the commodity specifications in market circulation. Methods The gray correlation, regression analysis and PCA, and HCA analysis were used to analysis the data, including the root length, plant height, dry weight, content of volatile oil, water-soluble extract, content of nardosine, moisture, total ash, acid-insoluble ash, etc., in order to comprehensively evaluate the quality of NH and NRR. Results The quality of NH and NRR were mainly correlated with the content of volatile oil and water soluble leach of NRR. Two variables corresponding to the dependent variable, aqueous extract and volatile oil, of total eight variables had significant influences between NH and NRR (P < 0.01). Conclusion The multidimensional statistical analysis of medicinal material quality illustrated an obvious difference between NH and NRR. It was conformed once again the NRR was to be the best for medical use, which was the same indexed regulations in different version of Chinese Pharmacopoeia. The NH was not absolutely substituted for NRR.
ABSTRACT
A review of literature indicates that diabetes mellitus was fairly well known and well conceived as an entity in India with complications like angiopathy, retinopathy, nephropathy, and causing neurological disorders. The antidiabetic study was carried out to estimate the anti hyperglycemic potential of Nardostachys Jatamansi rhizome’s hydro alcoholic extracts in alloxan induced diabetic rats over a period of two weeks. The hydroalcoholic extract HAE1 at a dose (500mg/kg) exhibited significant antihyperglycemic activity than extract HAE2 at a dose (500mg/kg) in diabetic rats. The hydroalcoholic extracts showed improvement in different parameters associated with diabetes, like body weight, lipid profile and biochemical parameters. Extracts also showed improvement in regeneration of β-cells of pancreas in diabetic rats. Histopathological studies strengthen the healing of pancreas by hydro alcoholic extracts (HAE1& HAE2) of Nardostachys Jatamansi, as a probable mechanism of their ant diabetic activity.
ABSTRACT
Objective:To prepare and evaluate a herbal antioxidant face cream which is made by the ethanol extract of Nardostachys jatamansi (Valerianceae). Methods: Antioxidant activity of ethanol extract was assessed by previously reported 2, 2-Diphenyl-1-picrylhydrazyl method. By discovering different types of formulations, such as oil in water, we were able to create several face creams respectively classified from F1 to F6, by incorporating different concentrations of stearic acid and acetyl alcohol. The evaluation of all formulations (F1 to F6) has been done by the analysis of different parameters like pH, viscosity, spread ability and stability. Results: An ethanol fraction analyzed from a sample of Nardostachys jatamansi showed a significant antioxidant activity with an IC50 value of 58.39 μg/mL while for ascorbic acid the IC50 value was 46.68 μg/mL. Among the six formulations (F1-F6) F5 and F6 showed good spread ability, good consistency, homogeneity, appearance, pH;there is no proof of a separation phase and ease of removal. Also the formulations F5 and F6 showed no redness or edema or erythema and irritation during irritancy studies. Conclusions:These formulations can be safely used on the skin. Hence, the study suggests that the composition of extract and the base of the cream F5 and F6 are more stable and safe, but it may produce synergistic action.